Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elda Favari

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|October 30, 2004
Probucol inhibits ABCA1-mediated cellular lipid effluxElda Favari, Ilaria Zanotti, Francesca Zimetti, et al.
BBA Advances|April 21, 2023
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophagesAnouar Hafiane, Alessandro Pisaturo, Annalisa Ronca, et al.
Atherosclerosis|November 18, 2006
Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patientsGuido Franceschini, Laura Calabresi, Cinzia Colombo, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMPIlaria Zanotti, Francesco Potì, Elda Favari, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophagesMyNgan Duong, Heidi L Collins, Weijun Jin, et al.
Handbook of Experimental Pharmacology|December 20, 2014
Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functionsFabrizio Montecucco, Elda Favari, Giuseppe Danilo Norata, et al.
European Journal of Clinical Investigation|March 16, 2022
Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol-lowering treatments?Qidi Ying, Annalisa Ronca, Dick C Chan, et al.
The Journal of Biological Chemistry|January 1, 2004
Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoproteinElda Favari, Miriam Lee, Laura Calabresi, et al.
Biochemistry|October 21, 2009
Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1Elda Favari, Laura Calabresi, Maria Pia Adorni, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 6, 2020
Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issuesSilvia Fogacci, Federica Fogacci, Elda Favari, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|October 30, 2004
Probucol inhibits ABCA1-mediated cellular lipid effluxElda Favari, Ilaria Zanotti, Francesca Zimetti, et al.
BBA Advances|April 21, 2023
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophagesAnouar Hafiane, Alessandro Pisaturo, Annalisa Ronca, et al.
Atherosclerosis|November 18, 2006
Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patientsGuido Franceschini, Laura Calabresi, Cinzia Colombo, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMPIlaria Zanotti, Francesco Potì, Elda Favari, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophagesMyNgan Duong, Heidi L Collins, Weijun Jin, et al.
Handbook of Experimental Pharmacology|December 20, 2014
Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functionsFabrizio Montecucco, Elda Favari, Giuseppe Danilo Norata, et al.
European Journal of Clinical Investigation|March 16, 2022
Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol-lowering treatments?Qidi Ying, Annalisa Ronca, Dick C Chan, et al.
The Journal of Biological Chemistry|January 1, 2004
Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoproteinElda Favari, Miriam Lee, Laura Calabresi, et al.
Biochemistry|October 21, 2009
Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1Elda Favari, Laura Calabresi, Maria Pia Adorni, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 6, 2020
Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issuesSilvia Fogacci, Federica Fogacci, Elda Favari, et al.
Pageof 6